Keystone Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Keystone Wealth Services's BMY Position: Q1 2026 in Review
Keystone Wealth Services reduced its Bristol-Myers Squibb (BMY) stake by 9.3% in Q1 2026, selling an estimated $39.5K and leaving 6,621 shares worth $402K. The position accounts for 0.09% of the portfolio, ranked #213.
Keystone Wealth Services first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $562K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Keystone Wealth Services held 6,621 shares of Bristol-Myers Squibb worth $402K as of Q1 2026.
- Keystone Wealth Services sold 677 Bristol-Myers Squibb shares in Q1 2026, an estimated $39.5K.
- Bristol-Myers Squibb made up 0.09% of Keystone Wealth Services's portfolio in Q1 2026, its #213 holding.
- Keystone Wealth Services first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- Keystone Wealth Services's Bristol-Myers Squibb position peaked at $562K in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Keystone Wealth Services's 13F filing for Q1 2026, filed 13 May 2026.